Article

Autoradiographic study of pre- and postnatal distribution of cannabinoid receptors in human brain.

Functional Imaging Center, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA.
NeuroImage (Impact Factor: 6.13). 01/2002; 14(6):1463-8. DOI: 10.1006/nimg.2001.0939
Source: PubMed

ABSTRACT Cannabinoid receptors have been characterized and localized in the brain of several species, including human. The pre- and postnatal distribution of human brain CB1 receptors was investigated using quantitative autoradiography with [(3)H]CP55,940 as a ligand. Normal fetal brains (N = 8, gestational age 14-24 weeks)were obtained from voluntary abortions. Normal (drug and pathology free) adult human brains (N = 16, age 18-78) were obtained from the medical examiner's offices in New York City and Jaffa, Israel. Brains were stored frozen at -70 degrees C and sectioned (40 microm) at -15 degrees C. The radioligand (5 nM) was incubated with the sections for 3 h at room temperature. Washed and dried sections were exposed to tritium-sensitive film along with standards for 7-28 days and autoradiograms quantitated using NIH Image software. In the fetal human brain, low densities of THC-displaceable, region-specific binding could be observed as early as 14 weeks gestation. Receptor density increased slowly with gestational age but did not reach adult levels by the end of the second trimester (24 weeks gestation). In addition, the distribution pattern in the fetal brains was markedly different from the adult pattern. The most striking difference was the very low density of binding in the fetal caudate and putamen. In contrast, the globus pallidus pars medialis has almost-adult levels of cannabinoid receptors by 17-18 weeks gestation. The relatively low and regionally selective appearance of cannabinoid receptors in the fetal human brain may explain the relatively mild and selective nature of postnatal neurobehavioral deficits observed in infants exposed to cannabinoids in utero.

0 Bookmarks
 · 
85 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: roliferation, migration and organization during the formation of brain cortex layers. Cannabinoid-1 Receptor (CB1R) plays a role in brain cortex development. Melatonin neuroprotective is an agent. In this study using an experimental cortical dysplasia model, CB1R expression and the effect of melatonin on CB1R were investigated. Methods: Eighteen female Wistar albino rats were randomly divided into three groups (n=6). A single dose of intraperitoneal (i.p) saline (20 ml/kg) was administered in the 15th day of pregnancy in the rats group 1 (sham group). A single dose of i.p BCNU (20 mg/kg) was administered in the 15th day of pregnancy in the rats in group 2 (BCNU) and group 3 (BCNU+ Melatonin). In addition, i.p melatonin (10 mg/kg) starting on day 15 of pregnancy and continuing until the day of delivery were administered to the rats in group 3 (BCNU+Melatonin). Newborn brain sections were investigated using Luxol fast blue and anti-CB1R staining. Results: While the sham group had cerebral cortex stratification compatible with the normal newborn histology, it was observed that the stratification was disrupted in the group 2 and group 3. In the observed brain regions (cerebral cortex, cerebellar cortex and hippocampus), it was observed that CB1R immunoreactivity decreased in group 2 and 3. Conclusion: In an experimental cortical dysplasia model, it was seen that the administration of melatonin revealed a protective effect against the decrease in CB1R expression. It has been suggested that a decrease in CB1R expression would also play a role in cortical dysplasia formation mechanisms.
    Journal of Neurological Sciences 07/2014; 31(2):346-354. · 0.14 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The neurophysiological effects of prenatal marijuana exposure on response inhibition were assessed in 18- to 22-year-olds. Thirty-one participants from the Ottawa Prenatal Prospective Study (OPPS) performed a blocked design Go/No-Go task while neural activity was imaged with functional magnetic resonance imaging (fMRI). The OPPS is a longitudinal study that provides a unique body of information collected from each participant over 20 years, including prenatal drug history, detailed cognitive/behavioral performance from infancy to young adulthood, and current and past drug usage. The fMRI results showed that with increased prenatal marijuana exposure, there was a significant increase in neural activity in bilateral prefrontal cortex and right premotor cortex during response inhibition. There was also an attenuation of activity in left cerebellum with increased prenatal exposure to marijuana when challenging the response inhibition neural circuitry. Prenatally exposed offspring had significantly more commission errors than nonexposed participants, but all participants were able to perform the task with more than 85% accuracy. These findings were observed when controlling for present marijuana use and prenatal exposure to nicotine, alcohol and caffeine, and suggest that prenatal marijuana exposure is related to changes in neural activity during response inhibition that last into young adulthood.
    Neurotoxicology and Teratology 05/2004; DOI:10.1016/S0892-0362(04)00066-2 · 3.22 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background:Following the characterization of the chemical structure of D9-tetrahydrocannabinol (THC), the main psychoactive constituent of marijuana, researchers have moved on with scientific valuable explorations.Objectives:The aim of this review is to highlight the role of endocannabinoid system in neurodegenerative diseases.Materials and Methods:The article is a critical analysis of the most recent data currently present in scientific literature on the subject; a qualitative synthesis of only the most significant articles has been performed.Results:In central nervous system, endocannabinoids show a neuromodulatory function, often of retrograde type. This way, they play an important role in synaptic plasticity and in cognitive, motor, sensory and affective processes. In addition, in some acute or chronic pathologies of central nervous system, such as neurodegenerative and neuroinflammatory diseases, endocannabinoids can perform a pro-homeostatic and neuroprotective function, through the activation of CB1 and CB2 receptors. Scientific evidence shows that an hypofunction or a dysregulation of the endocannabinoid system may be responsible for some of the symptoms of diseases such as multiple sclerosis, amyotrophic lateral sclerosis, Huntington’s, Parkinson’s and Alzheimer’s diseases.Conclusions:The important role played by endocannabinoid system promises interesting developments, in particular to evaluate the effectiveness of new drugs in both psychiatry and neurology.
    12/2013; 2(3):100-106. DOI:10.5812/ijhrba.9222
    This article is viewable in ResearchGate's enriched format

Full-text (4 Sources)

Download
62 Downloads
Available from
May 28, 2014